ReviewBritish journal of haematology2026

Minimal residual disease in diffuse large B-cell lymphoma after first-line therapy: Defining the continuum from metabolic remission to molecular clearance.

Santino Caserta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.